價格 | ¥637 | ¥1380 | ¥2150 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-30 |
中文名稱:化合物 K777 | 英文名稱:K777 |
CAS:233277-99-1 | 品牌: TargetMol |
產地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.14% | 產品類別: 抑制劑 |
貨號: T15641 |
名稱 | K777 |
描述 | K777 is a potent, orally active and irreversible inhibitor of cysteine protease. K777 is a potent CYP3A4 inhibitor (IC50= 60 nM). K777 is also a selective CCR4 antagonist featuring the potent chemotaxis inhibition. K777 irreversibly inhibits Cruzain, which is the major cysteine protease of Trypansoma cruzi, and cathepsins B and L. K777 targets cathepsin-mediated cell entry and wxibits a broad-spectrum antiviral activity. K777 inhibits EBOV and SARS-CoV pseudovirus entry with IC50 values of 0.87 nM and 0.68 nM, respectively. |
體外活性 | K777 is a broad-spectrum antiviral and inhibits SARS-CoV, HCoV-229E, NL63, MERS-CoV, EBOV, SUDV, TAFV, RESTV, BEBOV, MARV and Nipah pseudovirus entry with IC50 values of 0.68 nM, 1.48 nM, 6.78 nM, 46.12 nM, 0.87 nM, 1.14 nM, 2.26 nM, 3.37 nM, 5.91 nM, 1.9 nM and 0.42 nM, respectively. K777 alone demonstrates up to 70% inhibition of 229E-S-mediated transduction in TMPRSS2 expressing cells. Simultaneous treatment with Camostat and K777 increases inhibition to ~ 90%[1]. K777 inhibits both CCL17 binding and CCL17-induced chemotaxis in Hut78 cells with IC50s of 57 and 8.9 nM, respectively. The K777-mediated inhibition of chemotaxis is potent even in the presence of a 10-fold higher concentration of CCL17. K777 induces CCR4 internalization with a 50% reduction of cell surface CCR4[3]. |
體內活性 | In C57BL/6 IFN-γR-KO mice, K777 ( 35-105 mg/kg; p.o.) rescues mice from otherwise lethal infections[4]. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 90 mg/mL (156.6 mM), Sonication is recommended. |
關鍵字 | APC 3316 | K777 | K-777 | K 777 | APC3316 |
相關產品 | Papain | Naringin | Pirfenidone | 1-Aminobenzotriazole | Fenofibrate | Tauroursodeoxycholate | Methoxsalen | Naringenin | Apigenin | 1-Ethynylnaphthalene | Tebuconazole | Diflubenzuron |
相關庫 | 腫瘤免疫治療小分子化合物庫 | 抗癌化合物庫 | 抗代謝疾病化合物庫 | 共價抑制劑庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產物,生化試劑,分子生物學,分子砌塊,生物技術服務 | 經營模式 | 貿易,工廠,試劑,定制,服務 |
產品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP1年
|
青島愷潤生物醫(yī)藥科技有限公司
|
2024-11-02 | |
¥198 |
VIP12年
|
上海陶術生物科技有限公司
|
2024-10-18 | |
詢價 |
VIP1年
|
廣州佳途科技股份有限公司
|
2024-10-23 | |
詢價 |
威海厚普生物科技有限公司
|
2024-08-26 |